Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters

Pregnancy, Unplanned Clinical Trial

Official title:
A Single-centre, Open-label, Crossover, Controlled, Randomized Study to Investigate the Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters in 30 Healthy Female Volunteers Over 3 Treatment Cycles

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate the impact of SH T00658ID (EV/DNG tablet) on hemostatic parameters in comparison to a reference oral contraceptive (OC) (SH D01155E) in a crossover design.

Clinical Trial Description

The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Pregnancy, Unplanned

Clinical Trial Details

NCT number	NCT00318799
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	Phase 2
Start date	April 2006
Completion date	May 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04661566` - Optimizing a Multi-Modal Intervention to Reduce Health-Risking Sexual Behaviors: Component Selection	N/A
Completed	`NCT01994317` - Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion	N/A
Completed	`NCT03736876` - A Healthy Relationships Program for Vulnerable Youth	N/A
Completed	`NCT01539720` - Levonorgestrel Intrauterine System For Emergency Contraception	N/A
Recruiting	`NCT06024616` - Group-based Life Skills and Health Empowerment for Married Women to Avoid Unintended Pregnancies in India	N/A